Lionhunter Capital Management’s TriSalus Life Sciences TLSI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-300,275
Closed -$1.37M – 115
2026
Q2
$1.37M Buy
+300,275
New +$1.19M 0.62% 45

Other funds holding TLSI

Lionhunter Capital Management's TLSI Position: Q3 2026 in Review

Lionhunter Capital Management sold out of TriSalus Life Sciences (TLSI) in Q3 2026, closing a stake of 300,275 shares — an estimated $1.37M sold.

Lionhunter Capital Management first reported a position in TLSI in Q2 2026 and held it in 1 quarter. The position peaked at $1.37M in Q2 2026. 81 funds tracked by Wall St. Rank hold TLSI as of Q3 2026.

  • Lionhunter Capital Management reported no remaining TriSalus Life Sciences position as of Q3 2026 after selling out during the quarter.
  • Lionhunter Capital Management sold 300,275 TriSalus Life Sciences shares in Q3 2026, an estimated $1.37M.
  • Lionhunter Capital Management first reported a position in TriSalus Life Sciences in Q2 2026 and held it in 1 quarter.
  • Lionhunter Capital Management's TriSalus Life Sciences position peaked at $1.37M in Q2 2026.
  • 81 funds tracked by Wall St. Rank held TriSalus Life Sciences as of Q3 2026.

Based on Lionhunter Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.